Biography • Life Sciences - Regulatory

Scott Bass heads Sidley's global life sciences team, coordinating pharmaceutical, medical device, food and dietary supplement matters in the United States, Europe and Asia. He is ranked internationally among the top authorities on FDA-related enforcement and regulatory issues, and has led audits and investigations involving off-label promotion, pharmacovigilance, PDMA, GMP, and fraud and abuse issues, as well as DEA and FTC matters. Scott has also acted as an expert on an EU Commission panel, an adviser on new China drug and device legislation, and as an adviser on an FDA dietary supplement website.

Scott has represented such companies as Bayer, Genentech, Colgate Palmolive, Allergan, Novartis, Cargill, Herbalife, and Roche in a number of regulatory and enforcement matters. His experience includes establishing the firm's stand-alone comprehensive food and drug regulatory practices in Brussels and China; leading many of the firm's FDA/healthcare investigations and audits for high-profile life sciences companies; advising pharmaceutical, biological, medical device and food clients on Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) and Quality System Regulation (QSR) matters across three continents; advising the Shanghai Institute for Food and Drug Safety in China on the formulation of new drug and device laws; leading dietary supplement and functional food analyses for top multinational companies; and teaching GMP training in China.

Scott served as an adjunct professor at Georgetown University Graduate School, as co-chair of the ABA food and drug law committee, and as chairman of the NY State Bar Association section on food, drug and cosmetic law.

Scott received his JD (cum laude) from the University of Michigan in 1975 and his BA from New York University in 1972. He is admitted in the District of Columbia and New York.